$DXCM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in DEXCOM INC. Get notifications about new insider transactions in DEXCOM INC for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 13 14 ... 27 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 18 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 80.00 | 7,173 | 573,840 | 72,334 | 79.5 K to 72.3 K (-9.02 %) |
Jan 18 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 9.80 | 7,173 | 70,295 | 79,507 | 72.3 K to 79.5 K (+9.92 %) |
Jan 18 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 80.00 | 10,000 | 800,000 | 72,334 | 82.3 K to 72.3 K (-12.15 %) |
Jan 18 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.63 | 10,000 | 76,300 | 82,334 | 72.3 K to 82.3 K (+13.82 %) |
Jan 18 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 80.00 | 8,927 | 714,160 | 72,334 | 81.3 K to 72.3 K (-10.99 %) |
Jan 18 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 9.80 | 8,927 | 87,485 | 81,261 | 72.3 K to 81.3 K (+12.34 %) |
Jan 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 9.80 | 3,200 | 31,360 | 727 | |
Jan 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 62.86 | 3,200 | 201,152 | 106,345 | 109.5 K to 106.3 K (-2.92 %) |
Jan 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 9.80 | 3,200 | 31,360 | 109,545 | 106.3 K to 109.5 K (+3.01 %) |
Jan 11 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Option Exercise | M | 8.85 | 3,000 | 26,550 | 31,939 | |
Jan 11 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 63.02 | 3,000 | 189,046 | 70,598 | 73.6 K to 70.6 K (-4.08 %) |
Jan 11 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Buy | M | 8.85 | 3,000 | 26,550 | 73,598 | 70.6 K to 73.6 K (+4.25 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 0.00 | 900 | 0 | 100 | |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.63 | 2,583 | 19,708 | 0 | |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.79 | 7,000 | 54,530 | 0 | |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.63 | 417 | 3,182 | 10,000 | |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 62.83 | 2,583 | 162,288 | 72,334 | 74.9 K to 72.3 K (-3.45 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.63 | 2,583 | 19,708 | 74,917 | 72.3 K to 74.9 K (+3.57 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 63.31 | 900 | 56,981 | 72,334 | 73.2 K to 72.3 K (-1.23 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 3.19 | 900 | 2,871 | 73,234 | 72.3 K to 73.2 K (+1.24 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 63.49 | 417 | 26,474 | 72,334 | 72.8 K to 72.3 K (-0.57 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.63 | 417 | 3,182 | 72,751 | 72.3 K to 72.8 K (+0.58 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 63.02 | 7,000 | 441,162 | 72,334 | 79.3 K to 72.3 K (-8.82 %) |
Jan 11 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.79 | 7,000 | 54,530 | 79,334 | 72.3 K to 79.3 K (+9.68 %) |
Jan 11 2017 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 63.50 | 1,511 | 95,949 | 441,266 | 442.8 K to 441.3 K (-0.34 %) |
Dec 28 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 62.17 | 3,182 | 197,831 | 19,097 | 22.3 K to 19.1 K (-14.28 %) |
Dec 19 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Gift | G | 0.00 | 10,000 | 0 | 55,882 | 65.9 K to 55.9 K (-15.18 %) |
Dec 16 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | S | 64.14 | 2,442 | 156,619 | 15,797 | 18.2 K to 15.8 K (-13.39 %) |
Dec 16 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Gift | G | 0.00 | 500 | 0 | 299,391 | 299.9 K to 299.4 K (-0.17 %) |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.79 | 3,925 | 30,576 | 0 | |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.79 | 2,637 | 20,542 | 7,000 | |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.25 | 3,438 | 24,926 | 0 | |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 64.81 | 3,925 | 254,371 | 72,334 | 76.3 K to 72.3 K (-5.15 %) |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.79 | 3,925 | 30,576 | 76,259 | 72.3 K to 76.3 K (+5.43 %) |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 64.81 | 3,438 | 222,810 | 72,334 | 75.8 K to 72.3 K (-4.54 %) |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.25 | 3,438 | 24,926 | 75,772 | 72.3 K to 75.8 K (+4.75 %) |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 64.81 | 2,637 | 170,898 | 72,334 | 75 K to 72.3 K (-3.52 %) |
Dec 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.79 | 2,637 | 20,542 | 74,971 | 72.3 K to 75 K (+3.65 %) |
Dec 12 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 64.46 | 2,167 | 139,685 | 442,777 | 444.9 K to 442.8 K (-0.49 %) |
Nov 28 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 70.19 | 3,182 | 223,350 | 22,279 | 25.5 K to 22.3 K (-12.50 %) |
Nov 28 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | S | 70.32 | 10,300 | 724,260 | 110,409 | 120.7 K to 110.4 K (-8.53 %) |
Nov 14 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 62.17 | 2,172 | 135,042 | 444,944 | 447.1 K to 444.9 K (-0.49 %) |
Nov 14 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 62.50 | 3,417 | 213,563 | 70,598 | 74 K to 70.6 K (-4.62 %) |
Oct 26 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | S | 80.75 | 2,471 | 199,544 | 74,215 | 76.7 K to 74.2 K (-3.22 %) |
Oct 26 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | S | 81.95 | 10,300 | 844,065 | 120,709 | 131 K to 120.7 K (-7.86 %) |
Oct 26 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 81.12 | 3,182 | 258,110 | 25,461 | 28.6 K to 25.5 K (-11.11 %) |
Oct 20 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 82.31 | 4,997 | 411,303 | 106,345 | 111.3 K to 106.3 K (-4.49 %) |
Oct 17 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | S | 81.87 | 7,000 | 573,101 | 299,891 | 306.9 K to 299.9 K (-2.28 %) |
Oct 12 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 84.41 | 3,560 | 300,508 | 74,015 | 77.6 K to 74 K (-4.59 %) |
Oct 12 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.63 | 11,000 | 83,930 | 2,583 | |
Oct 12 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 84.42 | 11,000 | 928,579 | 72,334 | 83.3 K to 72.3 K (-13.20 %) |
Oct 12 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.63 | 11,000 | 83,930 | 83,334 | 72.3 K to 83.3 K (+15.21 %) |
Oct 12 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 83.35 | 2,167 | 180,619 | 447,116 | 449.3 K to 447.1 K (-0.48 %) |
Oct 07 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 82.55 | 5,000 | 412,750 | 111,342 | 116.3 K to 111.3 K (-4.30 %) |
Sep 27 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | S | 94.00 | 10,300 | 968,196 | 131,009 | 141.3 K to 131 K (-7.29 %) |
Sep 27 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 93.97 | 3,182 | 299,000 | 28,643 | 31.8 K to 28.6 K (-10.00 %) |
Sep 23 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | S | 93.99 | 2,470 | 232,155 | 76,686 | 79.2 K to 76.7 K (-3.12 %) |
Sep 22 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 92.87 | 5,000 | 464,366 | 116,342 | 121.3 K to 116.3 K (-4.12 %) |
Sep 22 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Gift | G | 0.00 | 290 | 0 | 50,556 | 50.8 K to 50.6 K (-0.57 %) |
Sep 16 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | S | 91.79 | 7,000 | 642,527 | 306,891 | 313.9 K to 306.9 K (-2.23 %) |
Sep 14 2016 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 93.00 | 10,000 | 930,000 | 0 | 10 K to 0 (-100.00 %) |
Sep 14 2016 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 92.90 | 5,000 | 464,512 | 24,304 | 29.3 K to 24.3 K (-17.06 %) |
Sep 14 2016 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 30.11 | 7,500 | 225,854 | 4,791 | 12.3 K to 4.8 K (-61.02 %) |
Sep 13 2016 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 94.07 | 25,000 | 2,351,788 | 17,246 | 42.2 K to 17.2 K (-59.18 %) |
Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 3,525 | 330,373 | 77,575 | 81.1 K to 77.6 K (-4.35 %) |
Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 6,114 | 573,021 | 81,100 | 87.2 K to 81.1 K (-7.01 %) |
Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 93.65 | 3,560 | 333,392 | 87,214 | 90.8 K to 87.2 K (-3.92 %) |
Sep 13 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 93.72 | 4,223 | 395,791 | 83,582 | 87.8 K to 83.6 K (-4.81 %) |
Sep 13 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 93.72 | 4,445 | 416,597 | 87,805 | 92.3 K to 87.8 K (-4.82 %) |
Sep 13 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 93.72 | 6,312 | 591,577 | 141,309 | 147.6 K to 141.3 K (-4.28 %) |
Sep 13 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 93.72 | 4,001 | 374,984 | 147,621 | 151.6 K to 147.6 K (-2.64 %) |
Sep 13 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 93.72 | 4,223 | 395,791 | 121,342 | 125.6 K to 121.3 K (-3.36 %) |
Sep 13 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 93.72 | 4,445 | 416,597 | 125,565 | 130 K to 125.6 K (-3.42 %) |
Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 3,525 | 330,373 | 77,575 | 81.1 K to 77.6 K (-4.35 %) |
Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 6,114 | 573,021 | 81,100 | 87.2 K to 81.1 K (-7.01 %) |
Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 93.65 | 3,560 | 333,392 | 87,214 | 90.8 K to 87.2 K (-3.92 %) |
Sep 13 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 93.72 | 3,556 | 333,278 | 79,156 | 82.7 K to 79.2 K (-4.30 %) |
Sep 13 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 93.72 | 2,667 | 249,958 | 82,712 | 85.4 K to 82.7 K (-3.12 %) |
Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 93.72 | 3,556 | 333,279 | 50,846 | 54.4 K to 50.8 K (-6.54 %) |
Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 93.72 | 4,445 | 416,597 | 54,402 | 58.8 K to 54.4 K (-7.55 %) |
Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 65.80 | 6,666 | 438,623 | 58,847 | 52.2 K to 58.8 K (+12.77 %) |
Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 95.80 | 8,333 | 798,301 | 52,181 | 43.8 K to 52.2 K (+19.00 %) |
Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 95.80 | 6,666 | 638,603 | 61,334 | 68 K to 61.3 K (-9.80 %) |
Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 95.80 | 8,333 | 798,301 | 68,000 | 76.3 K to 68 K (-10.92 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.63 | 12,000 | 91,560 | 13,583 | |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 92.06 | 7,071 | 650,965 | 3,499 | 10.6 K to 3.5 K (-66.90 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 93.72 | 4,001 | 374,984 | 10,570 | 14.6 K to 10.6 K (-27.46 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 93.72 | 6,312 | 591,578 | 14,571 | 20.9 K to 14.6 K (-30.23 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 95.80 | 7,500 | 718,500 | 20,883 | 13.4 K to 20.9 K (+56.04 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 95.80 | 11,833 | 1,133,601 | 13,383 | 1.6 K to 13.4 K (+763.42 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 95.80 | 7,500 | 718,500 | 72,334 | 79.8 K to 72.3 K (-9.39 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 95.80 | 11,833 | 1,133,601 | 79,834 | 91.7 K to 79.8 K (-12.91 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 93.66 | 12,000 | 1,123,909 | 91,667 | 103.7 K to 91.7 K (-11.58 %) |
Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.63 | 12,000 | 91,560 | 103,667 | 91.7 K to 103.7 K (+13.09 %) |
Sep 13 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 93.72 | 13,335 | 1,249,791 | 313,891 | 327.2 K to 313.9 K (-4.08 %) |
Sep 13 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 93.72 | 8,001 | 749,875 | 327,226 | 335.2 K to 327.2 K (-2.39 %) |
Sep 13 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 93.72 | 2,203 | 206,471 | 449,283 | 451.5 K to 449.3 K (-0.49 %) |
Sep 09 2016 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 94.63 | 1,800 | 170,325 | 15,643 | 17.4 K to 15.6 K (-10.32 %) |
Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 4,999 | 15,947 | 0 | |
Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 94.45 | 4,999 | 472,156 | 130,010 | 135 K to 130 K (-3.70 %) |
Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 4,999 | 15,947 | 135,009 | 130 K to 135 K (+3.85 %) |
Sep 09 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 95.59 | 5,145 | 491,830 | 65,882 | 71 K to 65.9 K (-7.24 %) |
Sep 09 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 95.01 | 5,595 | 531,571 | 71,027 | 76.6 K to 71 K (-7.30 %) |
Sep 06 2016 | DXCM | DEXCOM INC | LORD JONATHAN T MD | Director | Sell | S | 91.50 | 10,000 | 915,000 | 52,820 | 62.8 K to 52.8 K (-15.92 %) |
Sep 01 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 92.14 | 10,000 | 921,356 | 76,622 | 86.6 K to 76.6 K (-11.54 %) |
Aug 26 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 92.72 | 10,000 | 927,151 | 86,622 | 96.6 K to 86.6 K (-10.35 %) |
Aug 26 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 4,999 | |
Aug 26 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 91.72 | 5,000 | 458,600 | 129,979 | 135 K to 130 K (-3.70 %) |
Aug 26 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
Aug 25 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 90.89 | 3,182 | 289,224 | 31,825 | 35 K to 31.8 K (-9.09 %) |
Aug 25 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | S | 90.74 | 10,300 | 934,588 | 151,622 | 161.9 K to 151.6 K (-6.36 %) |
Aug 24 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 91.11 | 10,000 | 911,115 | 96,622 | 106.6 K to 96.6 K (-9.38 %) |
Aug 24 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 90.51 | 10,000 | 905,108 | 106,622 | 116.6 K to 106.6 K (-8.57 %) |
Aug 23 2016 | DXCM | DEXCOM INC | ALTMAN STEVEN R | Director | Sell | S | 90.91 | 3,500 | 318,177 | 15,142 | 18.6 K to 15.1 K (-18.77 %) |
Aug 22 2016 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 90.77 | 25,000 | 2,269,233 | 42,246 | 67.2 K to 42.2 K (-37.18 %) |
Aug 22 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 90.63 | 20,000 | 1,812,516 | 116,622 | 136.6 K to 116.6 K (-14.64 %) |
Aug 22 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 90.77 | 20,000 | 1,815,326 | 136,622 | 156.6 K to 136.6 K (-12.77 %) |
Aug 17 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | S | 90.78 | 7,000 | 635,473 | 335,227 | 342.2 K to 335.2 K (-2.05 %) |
Aug 17 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 91.01 | 14,942 | 1,359,858 | 156,622 | 171.6 K to 156.6 K (-8.71 %) |
Aug 15 2016 | DXCM | DEXCOM INC | LORD JONATHAN T MD | Director | Sell | S | 90.50 | 5,000 | 452,503 | 126,373 | 131.4 K to 126.4 K (-3.81 %) |
Aug 15 2016 | DXCM | DEXCOM INC | LORD JONATHAN T MD | Director | Sell | S | 90.78 | 5,000 | 453,896 | 131,373 | 136.4 K to 131.4 K (-3.67 %) |
Aug 15 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 91.03 | 10,900 | 992,280 | 171,564 | 182.5 K to 171.6 K (-5.97 %) |
Aug 12 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 9,999 | |
Aug 12 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 90.26 | 5,000 | 451,300 | 129,979 | 135 K to 130 K (-3.70 %) |
Aug 12 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
Aug 11 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 91.10 | 35,000 | 3,188,623 | 182,464 | 217.5 K to 182.5 K (-16.09 %) |
Aug 11 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 91.00 | 2,168 | 197,288 | 451,486 | 453.7 K to 451.5 K (-0.48 %) |
Aug 11 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 91.07 | 3,560 | 324,217 | 90,774 | 94.3 K to 90.8 K (-3.77 %) |
Aug 11 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.63 | 32,000 | 244,160 | 25,583 | |
Aug 11 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 91.06 | 32,000 | 2,913,978 | 91,667 | 123.7 K to 91.7 K (-25.88 %) |
Aug 11 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.63 | 32,000 | 244,160 | 123,667 | 91.7 K to 123.7 K (+34.91 %) |
Aug 11 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Option Exercise | M | 8.79 | 20,000 | 175,800 | 43,649 | |
Aug 11 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | S | 90.98 | 20,000 | 1,819,552 | 342,227 | 362.2 K to 342.2 K (-5.52 %) |
Aug 11 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Buy | M | 8.79 | 20,000 | 175,800 | 362,227 | 342.2 K to 362.2 K (+5.84 %) |
Aug 10 2016 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 90.52 | 6,000 | 543,131 | 29,304 | 35.3 K to 29.3 K (-17.00 %) |
Aug 09 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Option Exercise | M | 11.33 | 4 | 45 | 0 | |
Aug 09 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Buy | M | 11.33 | 4 | 45 | 161,922 | 161.9 K to 161.9 K (0.00 %) |
Aug 09 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 9.80 | 25,000 | 245,000 | 28,073 | |
Aug 09 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 91.22 | 25,000 | 2,280,375 | 91,667 | 116.7 K to 91.7 K (-21.43 %) |
Aug 09 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 9.80 | 25,000 | 245,000 | 116,667 | 91.7 K to 116.7 K (+27.27 %) |
Aug 09 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 91.29 | 20,000 | 1,825,798 | 217,464 | 237.5 K to 217.5 K (-8.42 %) |
Aug 09 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 64.50 | 15,000 | 967,572 | 457,991 | 473 K to 458 K (-3.17 %) |
Aug 02 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | S | 93.00 | 10,000 | 930,000 | 12,599 | 22.6 K to 12.6 K (-44.25 %) |
Aug 02 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | S | 91.00 | 5,000 | 455,000 | 22,599 | 27.6 K to 22.6 K (-18.12 %) |
Jul 28 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 14,999 | |
Jul 28 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 88.14 | 5,000 | 440,700 | 129,979 | 135 K to 130 K (-3.70 %) |
Jul 28 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
Jul 26 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | S | 88.48 | 10,000 | 884,800 | 27,599 | 37.6 K to 27.6 K (-26.60 %) |
Jul 26 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | S | 87.33 | 10,300 | 899,473 | 161,918 | 172.2 K to 161.9 K (-5.98 %) |
Jul 26 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 87.31 | 3,182 | 277,822 | 35,007 | 38.2 K to 35 K (-8.33 %) |